Complete cytogenetic remission after decitabine treatment in a patient with secondary AML harbouring high p15INK4b gene methylation and high global DNA methylation.
Lehmann
Ulrich
U
Dobbelstein
Christiane
C
Fenner
Martin
M
Römermann
Daniel
D
Hasemeier
Britta
B
Metzig
Kathleen
K
Steinemann
Doris
D
Büsche
Guntram
G
Krauter
Jürgen
J
Ganser
Arnold
A
Kreipe
Hans
H
D001374:Azacitidine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D050762:Cyclin-Dependent Kinase Inhibitor p15 / Q000235:genetics*; D003582:Cytogenetics / Q000639:trends; D019175:DNA Methylation / Q000187:drug effects* / Q000235:genetics; D000077209:Decitabine; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000235:genetics; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
D050762:Cyclin-Dependent Kinase Inhibitor p15; D000077209:Decitabine; D001374:Azacitidine